Skip to main content
Clinical Trials/IRCT2014111017935N3
IRCT2014111017935N3CompletedPhase 2

Comparison of pre-emptive ibuprofen, acetaminophen, and placebo administration in reducing pain during upper primary molar pulp therapy

Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences of Yazd0 sites75 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
6 years to 10 years (—)
Sex
All

Inclusion Criteria

  • children ages 6–12, who has primary maxillary molar spontaneous pain; no history of any systemic disease (renal, liver or digestion diseases); no history of prolonged bleeding; no history of platelet disorders; no history of hypersensitivity or allergic reactions to analgesics or any of the drugs tested.
  • Exclusion criteria: Patients taking analgesics within 5 hours prior to the dental procedure; uncooperative and anxious children.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences of Yazd

Similar Trials

se of analgesics in pain reduction in... | Clinical Trial